Li2P INSERM UMR 1125
Physiopathologie, cibles et thérapies de la polyarthrite rhumatoïde
2009
Publications du Li2P INSERM UMR 1125
2009
Neurological symptoms in patients with biopsy proven celiac disease. Bürk K, Farecki ML, Lamprecht G, Roth G, Decker P, Weller M, Rammensee HG, Oertel WHO. Mov Disord, 2009, 24:2358-62.
Neutrophils, dendritic cells and chromatin-mediated pathogenesis in systemic lupus erythematosus. Lindau D, Decker P. Autoimmunity, 2009, 42:254-6.
Chromatin modifications, oxidative stress and nucleosome autoantibodies. In: The epigenetics of autoimmune diseases. Erbacher A, Decker P. 2009, 119-34. Editor, Moncef Zouali; Publisher, Wiley Inc., New York.
Active immunization to tumor necrosis factor-alpha is effective in treating chronic established inflammatory disease: a long-term study in a transgenic model of arthritis. Delavallée L, Semerano L, Assier E, Vogel G, Vuagniaux G, Laborie M, Zagury D, Bessis N, Boissier MC. Arthritis Res Ther. 2009;11(6):R195. Epub 2009 Dec 23.
Regulatory T cells (Treg) in rheumatoid arthritis. Boissier MC, Assier E, Biton J, Denys A, Falgarone G, Bessis N. Joint Bone Spine. 2009;76:10-4.
No evidence of major effects in several Toll-like receptor gene polymorphisms in rheumatoid arthritis. Jaen O, Petit-Teixeira E, Kirsten H, Ahnert P, Semerano L, Pierlot C, Cornelis F, Boissier MC, Falgarone G; European Consortium on Rheumatoid Arthritis Families. Arthritis Res Ther. 2009;11:R5. Epub 2009 Jan 13.